Figure 4. Subgroup Analyses of the Primary Outcome.

A, The results of 6 studies in patients with remission ^{27,39,40,43,44,47} were compared with patients without remission. B, Second-generation antipsychotics^{27,32,33,34,35,36,45,46,50,51,52,53,54,55} were compared with first-generation antipsychotics^{37,38,39,40,41,42,43,44,45,47,48,49} and the primary analysis. C, Oral formulations were compared with long-acting injectable medications.